Literature DB >> 32372752

Case Report: Diagnosis of COVID-19 versus Tropical Diseases in Pakistan.

Syed Muhammad Mashhood Ali Bokhari1, Fatima Mahmood1, Syed Muhammad Saud Ali Bokhari2.   

Abstract

A 25-year-old medical student presented in Multan, Pakistan with a high fever, cough, myalgia, and diarrhea consistent with the typical signs and symptoms of novel coronavirus disease (COVID-19). The patient had traveled to high COVID-19-risk areas within Pakistan and had no significant medical and surgical history. Based on nasopharyngeal and oropharyngeal swab testing, the patient was found to be negative for COVID-19. He subsequently developed a diffuse rash and had serology consistent with dengue and measles. The patient was treated symptomatically, and his condition gradually improved over 7 days. This case highlights the high prevalence of many tropical diseases in low-income countries and the need for clinicians to consider alternate diagnoses in addition to testing for COVID-19 during the pandemic.

Entities:  

Mesh:

Year:  2020        PMID: 32372752      PMCID: PMC7263525          DOI: 10.4269/ajtmh.20-0356

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


CASE

A 25-year-old man presented to the emergency department of Nishtar Hospital, Multan, Pakistan with a 3-day history of high fever, chills, dry cough, myalgias, and diarrhea. He reported a sudden onset of symptoms. The patient is a medical student with no prior medical history. He reported recent travel with his family to Islamabad and Karachi, regions with known novel coronavirus disease (COVID-19) transmission, but family members denied similar complaints. The patient’s childhood and adult immunization records showed that all immunizations were up to date. Considering the emergence of COVID-19 and the patient’s travel history, he was admitted to the hospital. Droplet and contact precautions were initiated. The staff caring for the patient were provided appropriate personal protective equipment. In the ward, the patient was continuously shivering, with a temperature of 39.5°C, pulse 140 per minute, blood pressure 95/60 mm Hg, respiratory rate 18 per minute, and oxygen saturation 99% while breathing ambient air. Breath sounds were equal and clear in both lung fields. Chest radiographs showed no abnormalities. Initial laboratory tests were mostly unremarkable but showed mild elevation of liver function tests (Table 1). Nasopharyngeal and oropharyngeal swabs were tested for severe acute respiratory syndrome-coronavirus-2 by reverse transcriptase–Polymerase chain reaction, and both tests were negative. Therefore, we decided to steer the patient’s management toward other infectious diseases within our differential diagnosis.
Table 1

Clinical laboratory results

VariableReference rangeHospital day 1Hospital day 3
Sodium (mmol/L)136–145137138
Potassium (mmol/L)3.5–5.13.23.3
Chloride (mmol/L)98–107101100
Creatinine (mg/dL)0.7–1.30.73
ESR (mm/hour)1–2028
Total protein (g/dL)6.0–8.56.1
Albumin (g/dL)3.2–4.83.3
Aspartate aminotransferase (U/L)< 3583
Alanine aminotransferase (U/L)< 4595
Alkaline phosphatase (U/L)50–116112
Lactate dehydrogenase (U/L)120–246240
Total bilirubin (mg/dL)0.2–1.10.2
Hb (g/dL)13–1814.414.2
Hct (%)38–524244
Platelets (×109/L)150–400157145
White blood cell count (×109/L)4–117.48
Neutrophils (%)40–755052
Lymphocytes (%)20–503534
Monocytes (%)2–10108
Eosinophils (%)1–656
INR0.8–1.11.0

ESR = erythrocyte sedimentation rate; INR = international normalized ratio.

Clinical laboratory results ESR = erythrocyte sedimentation rate; INR = international normalized ratio. The patient was treated with intravenous hydration, ceftriaxone, metronidazole, and paracetamol. Initially, he experienced relapsing high fevers, productive cough, severe myalgias, and worsening diarrhea. On the third day of hospital admission, the patient developed a maculopapular rash on the face and trunk, which gradually spread to the extremities over 2 days. To evaluate the rash, measles and varicella antibody tests were also conducted. Microscopy of thick and thin smears for malaria, serology and surface antigen markers for viral hepatitis, and bacterial blood and stool cultures were negative. Testing for dengue showed positive IgM titers (1.6 U/L) and borderline NS1 antigen (0.8 µg/mL) results. Further serologic investigation revealed elevated IgM (137 U/L) against measles virus and negative serology for varicella. The same treatment measures were continued. By day 7, the patient’s fever, rash, and diarrhea had subsided; intravenous access was removed; and he was discharged.

DISCUSSION

The WHO defines tropical diseases as infectious diseases that thrive in hot and humid tropical conditions, including dengue, malaria, leishmaniasis, schistosomiasis, and onchocerciasis, among several others.[1] Despite medical advancements and numerous control measures, many developing nations still face the burden of tropical diseases. Dengue fever is one of the most prevalent diseases in Pakistan, with more than 50,000 cases and resulting in more than 90 deaths in 2019.[2] Multan district faced a devastating outbreak of dengue fever in 2015.[3] In our case, the patient raised suspicion for concomitant measles infection based on the WHO clinical case definition, which defines suspected measles as fever and maculopapular rash with cough, coryza, or conjunctivitis.[4] Although the appearance of high titers of measles IgM seems puzzling in an immunocompetent, immunized patient, possible explanations for infection could be waning immunity, secondary vaccine failure, or prolonged exposure to a measles patient.[5] Aggressive vaccination campaigns against measles were accompanied by a 71% reduction in mortality and morbidity rates worldwide between 2000 and 2011, but Pakistan continues to face this disease burden, with 94 measles deaths in Punjab during early 2013.[6] Although COVID-19 is emerging as a pressing threat worldwide, this case underscores the need for clinicians practicing in Pakistan and other tropical regions to consider the possibility of common tropical diseases in all suspected patients. It also highlights the challenges facing the measles elimination campaign and the common threat of dengue in Pakistan.
Table 2

Microbiology report

TestReference rangeResults
Novel coronavirus disease RT-PCR testNegative
Dengue virus IgM (U/L)< 0.91.59
Dengue NS1 antigen (µg/mL)< 0.60.8
Measles IgM (U/mL)< 20136.6
InfluenzaNegative
Stool cultureNo growth after 7 days
Blood cultureNo growth after 7 days
Thick and thin smear microscopy for malariaNegative

RT-PCR = reverse transcription polymerase chain reaction.

  3 in total

1.  Diagnosis of measles by clinical case definition in dengue-endemic areas: implications for measles surveillance and control.

Authors:  V J Dietz; P Nieburg; D J Gubler; I Gomez
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

2.  Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.

Authors:  Carole J Hickman; Terri B Hyde; Sun Bae Sowers; Sara Mercader; Marcia McGrew; Nobia J Williams; Judy A Beeler; Susette Audet; Bryan Kiehl; Robin Nandy; Azaibi Tamin; William J Bellini
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

3.  Clinical Profiles of Dengue Fever Patients, during an Outbreak.

Authors:  Shafia Saba; Ata Ur Rehman Khan; Unsar Naeem-Ullah; Syed Haroon Masood Bokhari
Journal:  J Arthropod Borne Dis       Date:  2019-06-24       Impact factor: 1.198

  3 in total
  7 in total

Review 1.  Coronavirus Disease of 2019: a Mimicker of Dengue Infection?

Authors:  Joshua Henrina; Iwan Cahyo Santosa Putra; Sherly Lawrensia; Quinta Febryani Handoyono; Alius Cahyadi
Journal:  SN Compr Clin Med       Date:  2020-07-13

2.  Concerns and public health challenges for arboviral and other respiratory infections amidst SARS-CoV-2 pandemic.

Authors:  Ankita Agarwal; Deepti Chaurasia; Paban Kumar Dash
Journal:  Pathog Glob Health       Date:  2020-09-25       Impact factor: 2.894

3.  Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.

Authors:  Yi-Ling Cheng; Chiao-Hsuan Chao; Yen-Chung Lai; Kun-Han Hsieh; Jen-Ren Wang; Shu-Wen Wan; Hong-Jyun Huang; Yung-Chun Chuang; Woei-Jer Chuang; Trai-Ming Yeh
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

4.  Dengue and COVID-19, overlapping epidemics? An analysis from Colombia.

Authors:  Jaime A Cardona-Ospina; Kovy Arteaga-Livias; Wilmer E Villamil-Gómez; Carlos E Pérez-Díaz; D Katterine Bonilla-Aldana; Álvaro Mondragon-Cardona; Marco Solarte-Portilla; Ernesto Martinez; Jose Millan-Oñate; Eduardo López-Medina; Pio López; Juan-Carlos Navarro; Luis Perez-Garcia; Euler Mogollon-Rodriguez; Alfonso J Rodríguez-Morales; Alberto Paniz-Mondolfi
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 20.693

5.  Low risk of serological cross-reactivity between dengue and COVID-19.

Authors:  Michele Spinicci; Alessandro Bartoloni; Antonia Mantella; Lorenzo Zammarchi; Gian Maria Rossolini; Alberto Antonelli
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-08-14       Impact factor: 2.743

6.  Experience of a Tertiary Hospital in Singapore with Management of a Dual Outbreak of COVID-19 and Dengue.

Authors:  Liang En Wee; Benjamin Pei Zhi Cherng; Edwin Philip Conceicao; Kenneth Choon-Meng Goh; Wei Yee Wan; Kwan Ki Karrie Ko; May Kyawt Aung; Xiang Ying Jean Sim; Limin Wijaya; Moi Lin Ling; Indumathi Venkatachalam
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

Review 7.  Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.

Authors:  Sébastien Boutin; Dagmar Hildebrand; Steeve Boulant; Michael Kreuter; Jule Rüter; Srinivas Reddy Pallerla; Thirumalaisamy P Velavan; Dennis Nurjadi
Journal:  Cell Mol Life Sci       Date:  2021-07-05       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.